Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-24

Clinical Trial Update: Effects of Sandostatin LAR® in Acromegaly [Phase 4]

View source ↗

Summary

This update reports the completion and results of a Phase 4 trial evaluating Sandostatin LAR in patients with acromegaly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sandostatin LAR (octreotide)

Snippet

Sponsor: Columbia University | Conditions: Acromegaly | Phase 4 | Status: COMPLETED | Results posted: 2024-07-24